Brief: Tivic Health Systems Q3 Net Income USD -2.596 Million
Brief: Tivic Health Systems Q2 Net Income USD -1.931 Million
Brief: Tivic Health Systems Says Entered Amended License Agreement With Statera Biopharma - SEC Filing
Brief: Tivic Health Systems Inc Files For Resale Of 8.4 Million Shares Of Common Stock By Selling Stockholder
Brief: Tivic Health Systems Q1 Net Income USD -1.502 Million
Tivic Health Systems soars after meetings with White House, FDA
Brief: Tivic Health Reports White House Briefing And FDA Meetings Secured Positive Interest In Potential Military And Defense Applications Of Its Product Candidates
Brief: Tivic Health Systems Regains Compliance With Nasdaq Minimum Bid Price Listing Rule
Brief: Tivic Health Systems enters equity purchase agreement with Mast Hill Fund
Brief: Tivic Health Systems Announces Reverse Stock Split
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Tivic Health Systems Inc - On Dec 27, Not In Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Tivic Health Systems Q3 Net Income USD -1.431 Million
Brief: Tivic Health Appoints Lisa Wolf As Interim Chief Financial Officer
Brief: Tivic Health Systems Says Lisa Wolf Appointed Interim CFO Effective October 1
Brief: Tivic Health Systems Q2 Net Income USD -1.266 Million
Brief: Tivic Health Systems Inc - On May 21, Entered Into A Sublease Termination Agreement With Czarnowski Display Service, Inc.
Brief: Tivic Health Partners With The Feinstein Institutes To Advance Its Patent-Pending, Non-Invasive Cervical Vagus Nerve Stimulation Begins Optimization Of Ncvns For Use In Clinical Indications